5DX — Meta Health Cashflow Statement
0.000.00%
Last trade - 00:00
- SG$10.31m
- SG$10.91m
- SG$4.61m
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.117 | -1.94 | 7.67 | -7.37 | -3.33 |
Depreciation | |||||
Non-Cash Items | 0.673 | 0.32 | -7.56 | 1.55 | -0.084 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.46 | -0.773 | -2.62 | 0.949 | -0.354 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 5.37 | 0.478 | 0.289 | -2.25 | -2.24 |
Capital Expenditures | -1.54 | -0.394 | -0.315 | -0.494 | -0.414 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1 | 4.9 | 3.5 | -1.76 | 5.11 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.54 | 4.51 | 3.19 | -2.25 | 4.7 |
Financing Cash Flow Items | -0.688 | -0.432 | -0.45 | -0.821 | -0.394 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.79 | -3.02 | 2.48 | -2.3 | -0.284 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.058 | 2 | 5.97 | -6.94 | 1.95 |